Skip to main content
Year archive

HK inno.N Corporation — 2022 filings

All 40 regulatory filings released by HK inno.N Corporation (195940) in 2022, sourced directly from the official regulator.

40 Filings
2022 Period
2022 filings (40)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2022-12-15 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-12-13 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-11-29 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
지속가능경영보고서등관련사항(자율공시)
Report Publication Announcement
2022-11-09 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-11-07 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q3 2022
2022-10-31 Korean
투자판단관련주요경영사항(케이캡정(테고프라잔) 인도네시아 품목 허가 승인)
Regulatory Filings
2022-10-11 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-09-21 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares
2022-08-09 Korean
신탁계약해지결과보고서
Transaction in Own Shares
2022-08-09 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release H1 2022
2022-08-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-05-30 Korean
투자판단관련주요경영사항(케이캡정(테고프라잔) 필리핀 품목 허가 승인)
Regulatory Filings
2022-05-23 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
[기재정정]신규시설투자등
Regulatory Filings
2022-05-13 Korean
본점소재지변경
Regulatory Filings
2022-05-12 Korean
[기재정정]연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2022
2022-05-11 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares
2022-05-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-05-09 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2022
2022-05-09 Korean
투자판단관련주요경영사항(COVID-19 예방 백신(IN-B009) 국내 임상1상 시험 자진 중단)
Legal Proceedings Report
2022-05-09 Korean
소속부변경
Regulatory Filings
2022-04-29 Korean
투자판단관련주요경영사항(케이캡정(테고프라잔) 중국 품목허가 획득)
Regulatory Filings
2022-04-13 Korean
[기재정정]투자판단관련주요경영사항(케이캡정(테고프라잔) 중국 품목허가 획득)
Regulatory Filings
2022-04-13 Korean
투자판단관련주요경영사항(건강한 미국인을 대상으로 Tegoprazan의 약동/약력학적 특성 및 안전성/내약성을 평가하기 위한 제1상 임상시험 결과)
Regulatory Filings
2022-04-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-03-25 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-17 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-17 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2022-03-10 Korean
주주총회집중일개최사유신고
AGM Information
2022-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-09 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2022-02-09 Korean
대표이사변경
Board/Management Information
2022-01-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-01-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-01-13 Korean